Bioline, a Meridian Bioscience company, this week launched the EPIK Quantification and EPIK Amplification kits.
The new kits were developed to meet the needs of researchers using PCR and real-time PCR in epigenetic research. They are based on the company's MyTaq and SensiFAST polymerases and a novel EPIKORE buffer system, formulated to overcome the challenges associated with bisulfite-modified DNA templates. The company said that they kits' speed, specificity, and reliability make them well-suited to high-throughput epigenetic studies.